- Sections
- C - Chimiemétallurgie
- C07C - Composés acycliques ou carbocycliques
- C07C 275/50 - Y étant un atome d'hydrogène ou de carbone acyclique
Détention brevets de la classe C07C 275/50
Brevets de cette classe: 29
Historique des publications depuis 10 ans
|
7
|
3
|
1
|
1
|
1
|
3
|
0
|
0
|
3
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Hangzhou DAC Biotech Co., Ltd | 113 |
4 |
| Merck Patent GmbH | 5729 |
2 |
| Korea University Research and Business Foundation | 3271 |
2 |
| KYORIN Pharmaceutical Co., Ltd. | 159 |
2 |
| Kyungpook National University Industry-Academic Cooperation Foundation | 1238 |
2 |
| The Regents of the University of California | 20778 |
1 |
| Syngenta Crop Protection AG | 6710 |
1 |
| Showa Denko K.K. | 2069 |
1 |
| Arbor Pharmaceuticals, LLC | 64 |
1 |
| Ecolab USA Inc. | 5803 |
1 |
| Exigence Technologies Inc. | 9 |
1 |
| Industry-University Cooperation Foundation Hanyang University | 1010 |
1 |
| Japan Tobacco Inc. | 3550 |
1 |
| Stoller Enterprises, Inc. | 16 |
1 |
| Suzhou M-conj Biotech Co., Ltd. | 4 |
1 |
| University of Manitoba | 444 |
1 |
| The Wistar Institute of Anatomy and Biology | 483 |
1 |
| XenoPort, Inc. | 75 |
1 |
| Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. | 1354 |
1 |
| Suzhou Elite New Pharmaceutical Research and Development Co., Ltd. | 1 |
1 |
| Autres propriétaires | 2 |